about
Excavatolide B inhibits nonsmall cell lung cancer proliferation by altering peroxisome proliferator activated receptor gamma expression and PTEN/AKT/NF-Kβ expression.Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.Estrogen and ERα enhanced β-catenin degradation and suppressed its downstream target genes to block the metastatic function of HA22T hepatocellular carcinoma cells via modulating GSK-3β and β-TrCP expression.Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma.Helioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice.A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.17β-Estradiol and/or estrogen receptor alpha blocks isoproterenol-induced calcium accumulation and hypertrophy via GSK3β/PP2A/NFAT3/ANP pathway.High density lipoprotein (HDL) reverses palmitic acid induced energy metabolism imbalance by switching CD36 and GLUT4 signaling pathways in cardiomyocyte.PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.Pharmacological benefits of neferine - A comprehensive review.Toxicity of Doxorubicin (Dox) to different experimental organ systems.Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo.Anti-apoptotic and pro-survival effect of protocatechuic acid on hypertensive hearts.Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma.Pharmalogical activities of antroquinonol - Mini reviewNeuroprotective Role of Phytochemicals16-Hydroxycleroda-3,13-dien-15,16-olide and N-Methyl-Actinodaphine Potentiate Tamoxifen-Induced Cell Death in Breast CancerTherapeutic applications of cannabinoidsCIP2A overexpression in Taiwanese oral cancer patientsA minireview of E4BP4/NFIL3 in heart failureRole of lncRNAs in the cancer development and progression and their regulation by various phytochemicalsDDR2 overexpression in oral squamous cell carcinoma is associated to lymph node metastasisBiomaterial aided differentiation and maturation of induced pluripotent stem cellsInsulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumorsLuteolin-7-O-Glucoside Inhibits Oral Cancer Cell Migration and Invasion by Regulating Matrix Metalloproteinase-2 Expression and Extracellular Signal-Regulated Kinase PathwayProtein phosphatase 2A as therapeutic targets in various disease modelsInnate-immune responses of tilapia (Oreochromis mossambicus) exposure to acute cold stressEffects of phytochemicals on cellular signaling: reviewing their recent usage approachesKHC-4 inhibits β-catenin expression in prostate cancer cellsAntrodia cinnamomea-An updated minireview of its bioactive components and biological activityCombination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells
P50
Q35899258-D4366AF0-481E-4E46-A81A-EFC77466A837Q36998120-4351138C-9E43-47F4-AC09-C69CD44F1461Q38785208-A6EF40CD-2C00-4470-9534-A5D009DEEE61Q41109724-AF9FC8DF-58C9-4CFF-98E0-3E45511493C0Q42700365-C691896C-8332-4621-906C-25D373A51A9AQ45949842-3D815DFD-4185-4D75-8AE3-0ABA2DE54725Q47405898-96E3A701-917C-497A-85FA-FA69DCC28769Q48060340-427C402B-5E5C-4E28-B782-C259141BE5E7Q48061653-C6564821-39D4-4682-B3B0-B5BAA8BD6A8AQ48128686-B51690F7-5C97-4B24-8D31-3E09C68E12F2Q51766112-910AE96F-9E41-4DC5-B256-87CD7C9D98D0Q52657482-D6D84351-5980-4965-8EE9-BB6B843336A0Q52724400-4C928A2E-9107-4DBA-856F-095375BA65ABQ54416837-07CFDECB-5B48-446E-B078-9850793AF3E3Q54759923-7A6B5916-976B-4CB6-BC46-30AA83DAFF31Q57812175-03676B9D-BB13-4AA0-9B8B-DF9741145743Q58692870-CCEE40E0-53D4-414E-9299-31AEAAD0614FQ58697456-EFAA808C-9FBF-4F7F-81D3-4B7DCB23A124Q61960167-BC5A1B8D-DFB8-4D46-821C-AB9FD05506CDQ64070891-BC3CC4C9-AA86-4A5F-A151-48B3701C460FQ64376996-5E08DB81-2D4A-4916-9E45-2FDC6F94E7A8Q88137132-80E45517-2115-4D12-88FF-8A113F114176Q89263730-D37C667F-DCAD-4365-B118-846BD6701769Q90630460-D5121477-36F1-4F6C-B833-CCA296764519Q90703971-D7EC4D30-BAE2-44C1-8BE9-89BDE20512D0Q90736739-AE547C51-55FE-4BFA-A314-835195A3CFC8Q91250935-0515805D-F0D4-47C9-A63A-48C2B3870D8EQ91448032-4D4069D2-92F0-4AD5-8577-5D9098804A5CQ91849888-DADF343B-BBED-41BF-A64F-467C88F9C7F0Q92016426-1A00BCF8-F372-45DF-A65A-7F73B406A175Q92333566-854D0FF6-2D43-46E5-91B2-AF9DED5DA00CQ92638918-9F8FFA3F-4DFF-4499-A30C-BA9DD6D5068F
P50
description
investigador
@es
onderzoeker
@nl
researcher
@en
name
Bharath Kumar Velmurugan
@ast
Bharath Kumar Velmurugan
@en
Bharath Kumar Velmurugan
@es
Bharath Kumar Velmurugan
@nl
type
label
Bharath Kumar Velmurugan
@ast
Bharath Kumar Velmurugan
@en
Bharath Kumar Velmurugan
@es
Bharath Kumar Velmurugan
@nl
prefLabel
Bharath Kumar Velmurugan
@ast
Bharath Kumar Velmurugan
@en
Bharath Kumar Velmurugan
@es
Bharath Kumar Velmurugan
@nl
P106
P1153
55946560300
P31
P496
0000-0002-4786-9913